Regeneron Pharmaceuticals, Inc. (REGN) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Core Insights - Regeneron has a compelling story to share, particularly regarding its clinical programs that are not currently reflected in its valuation [3] Company Overview - The company is actively working on various clinical programs aimed at bringing new treatments to patients, which are not being fully appreciated in the market [3] Conference Participation - Regeneron executives, including Chris Fenimore and Ryan Crowe, participated in the TD Cowen Conference, indicating strong attendance and interest in their presentation [2]